Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Perspective Therapeutics, Inc.

CIK 728387Updated Nov 19, 2026

Name history
IsoRay, Inc. · through Feb 16, 2023Isoray, Inc. · through Feb 16, 2023CENTURY PARK PICTURES CORP · through Aug 3, 2005

CATX price & chart

Provider market data

Loading TradingView…

AMEX:CATX on TradingView ↗

TradingView · Data may be delayed

About the company

Perspective Therapeutics, Inc. is a radiopharmaceutical development company pioneering advanced systemic treatments for cancers. The Company has proprietary technology that utilizes the alpha-generating isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. The Company is also developing complementary imaging techniques that incorporate the same targeting moieties, creating an opportunity to personalize treatment and optimize patient outcomes. This "theranostic" approach enables visualization of the specific tumor and subsequent treatment, potentially improving efficacy and minimizing toxicity.

8-K · 2026-11-09 · 0001193125-26-453708

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-103,121,000USD · FY 2025
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

Operating income-113,564,000USD · FY 2025
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

Diluted EPS-1.4USD per share · FY 2025
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q3 2023Q2 2026Q2 2025Q2 2024Q2 2023Q1 2023FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD———266,972,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

341,101,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

97,891,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

58,091,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

62,538,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

266,972,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

341,101,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

97,891,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

64,439,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Property, Plant and Equipment, NetUSD———76,597,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

57,321,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

5,576,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

1,684,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

1,999,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

76,597,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

57,321,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

5,576,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

1,976,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

GoodwillUSD—————24,062,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

0
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

——0
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

24,062,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

—
Intangible Assets, Net (Excluding Goodwill)USD——————0
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

—362,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

279,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

354,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

—
Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD———30,629,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

61,580,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

9,238,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

20,993,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

18,989,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

30,629,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

61,580,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

9,238,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

55,890,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD———6,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

116,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

1,165,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

1,363,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

—6,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

116,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

1,165,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

—
Inventory, NetUSD——————1,409,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

1,553,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

———1,396,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Assets, CurrentUSD———148,389,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

231,160,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

16,837,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

53,215,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

57,540,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

148,389,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

231,160,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

16,837,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

59,329,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Prepaid Expense and Other Assets, CurrentUSD———3,646,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

4,128,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

1,133,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

577,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

662,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

3,646,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

4,128,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

1,133,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

435,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Operating Lease, Right-of-Use AssetUSD———1,500,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

2,215,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

747,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

378,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

445,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

1,500,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

2,215,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

747,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

512,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Other Assets, NoncurrentUSD———486,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

405,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

487,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

236,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

101,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

486,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

405,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

487,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

107,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

LIABILITIES AND EQUITY
LiabilitiesUSD———59,941,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

50,433,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

22,712,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

3,449,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

4,836,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

59,941,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

50,433,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

22,712,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

3,162,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD———0
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

0
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

0
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

0
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

0
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

0
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

0
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

0
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

0
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Common Stock, Value, IssuedUSD———74,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

70,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

28,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

142,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

142,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

74,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

70,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

282,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

142,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Retained Earnings (Accumulated Deficit)USD———-334,840,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

-231,719,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

-152,440,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

-105,932,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

-102,665,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

-334,840,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

-231,719,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

-152,440,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

-98,597,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD———110,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

-51,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

———110,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

-51,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

——
Stockholders' Equity Attributable to ParentUSD284,645,000
Source

10-Q · 2025-11-10 · 0001193125-25-274328

As of 2025-03-31

229,891,000
Source

10-Q · 2025-11-10 · 0001193125-25-274328

As of 2024-03-31

118,028,000
Source

10-Q · 2024-11-12 · 0000950170-24-125399

As of 2023-03-31

207,031,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

290,668,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2024-12-31

75,179,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2023-12-31

54,642,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2022-12-31

57,702,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

207,031,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

290,668,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

75,179,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

61,277,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Additional Paid in Capital, Common StockUSD———541,687,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

522,368,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

227,591,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

160,432,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

160,225,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

541,687,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

522,368,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

227,337,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

159,732,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Liabilities and EquityUSD———266,972,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

341,101,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

97,891,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

58,091,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

62,538,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

266,972,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

341,101,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

97,891,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

64,439,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Current liabilities:
Liabilities, CurrentUSD———28,679,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

18,230,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

15,664,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

2,676,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

4,001,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

28,679,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

18,230,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

15,664,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

2,266,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Operating Lease, Liability, CurrentUSD———623,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

957,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

46,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

276,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

272,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

623,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

957,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

46,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

268,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Operating Lease, Liability, NoncurrentUSD———1,005,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

1,428,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

780,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

116,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

186,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

1,005,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

1,428,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

780,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

256,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

As of 2022-06-30

Deferred Income Tax Liabilities, NetUSD———1,702,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

2,495,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

4,592,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

——1,702,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

2,495,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

4,592,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

—
Other Liabilities, NoncurrentUSD———386,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

55,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

0
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

——386,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

55,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

——
Additional Financial Items
Cash, Cash Equivalents, and Short-term InvestmentsUSD————————144,700,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

226,900,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

——
Deferred Tax Liabilities, NetUSD————————1,702,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

2,495,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

4,592,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

—
Long-term DebtUSD————————1,625,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

1,677,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

1,725,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

—
Short-term InvestmentsUSD———114,108,000
Source

10-Q · 2026-08-10 · 0001193125-26-342512

As of 2025-12-31

165,336,000
Source

10-Q · 2025-08-13 · 0000950170-25-107619

As of 2024-12-31

0
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

22,764,000
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

35,123,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

As of 2022-09-30

114,108,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

165,336,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

0
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

—

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ3 2025Q3 2024Q3 2023Q2 2024Q2 2023Q1 2023FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization———————
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

—
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Share-based Payment Arrangement, Noncash ExpenseUSD—————465,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

8,966,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

5,387,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

3,738,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

1,087,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD—————-395,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

-110,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-1,049,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

426,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

-405,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Increase (Decrease) in InventoriesUSD—————95,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

——-359,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

2,673,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Deferred Income Tax Expense (Benefit)USD——————-793,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-2,097,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-2,651,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Net Cash Provided by (Used in) Operating ActivitiesUSD—————-1,763,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

-82,484,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-18,294,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-36,913,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

-7,710,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD—————-35,166,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

41,228,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-218,931,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

24,373,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

-284,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Payments to Acquire Property, Plant, and EquipmentUSD—————90,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

12,749,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

54,414,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

1,072,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

266,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD—————28,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

10,305,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

289,385,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

785,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

56,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD—————-36,901,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

-30,951,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

52,160,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-11,755,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

-7,938,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD————————84,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Income Taxes Paid, NetUSD——————30,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

———
Additional Financial Items
AmortizationUSD—————6,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

——40,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

41,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Share-based Payment Arrangement, ExpenseUSD—————465,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

8,966,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

5,221,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

3,143,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

1,087,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Amortization of Intangible AssetsUSD——————7,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

7,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

7,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

41,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Asset Retirement Obligation, Accretion ExpenseUSD—————8,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

——35,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

32,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Cash, Cash Equivalents, and Short-term InvestmentsUSD——————144,700,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

As of 2025-12-31

226,900,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

——
Debt Securities, Available-for-sale, Realized Gain (Loss)USD——————0
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

0
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
DepreciationUSD—————68,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

——946,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

248,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Foreign Currency Transaction Gain (Loss), before TaxUSD——————-250,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

———
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD——————0
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-27,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

0
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Gain (Loss) on Disposition of BusinessUSD——————0
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-59,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-4,170,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Gain (Loss) on Disposition of Property Plant EquipmentUSD——————0
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-27,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-22,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

0
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

General and Administrative ExpenseUSD—————3,114,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

30,233,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

26,613,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

21,064,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

6,621,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

GoodwillUSD———24,062,000
Source

10-Q · 2024-08-13 · 0000950170-24-096148

As of 2023-12-31

0
Source

10-Q · 2023-08-11 · 0001437749-23-023340

As of 2022-12-31

——0
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

As of 2024-12-31

24,062,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

As of 2023-12-31

—
Goodwill, Impairment LossUSD——————0
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

24,062,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD——————10,000,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

0
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Income (Loss) from Equity Method InvestmentsUSD——————-2,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-8,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-17,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Income Tax Expense (Benefit)USD——————-793,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-2,097,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-2,651,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

0
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Inventory Write-downUSD————————298,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Investment Income, InterestUSD—————140,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

8,114,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

10,515,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

934,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

119,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Net Income (Loss) Attributable to ParentUSD-18,177,000
Source

10-Q · 2025-11-10 · 0001193125-25-274328

2025-01-01 to 2025-03-31

-12,284,000
Source

10-Q · 2025-11-10 · 0001193125-25-274328

2024-01-01 to 2024-03-31

-371,000
Source

10-Q · 2024-11-12 · 0000950170-24-125399

2023-01-01 to 2023-03-31

——-4,068,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

-103,121,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-79,279,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-46,508,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

-7,272,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Net Income (Loss) Available to Common Stockholders, BasicUSD—————————-7,272,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Nonoperating Income (Expense)USD—————140,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

9,136,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

10,459,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

835,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

119,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Operating ExpensesUSD—————4,622,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

114,448,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

92,340,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

42,375,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

12,007,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Operating Lease, ExpenseUSD—————79,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

100,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

800,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

97,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

312,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Proceeds from Issuance of Common StockUSD———————275,807,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

364,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Proceeds from Stock Options ExercisedUSD—————28,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

371,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

1,253,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

554,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

56,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Revenue from Contract with Customer, Including Assessed TaxUSD—————1,717,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

——1,434,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

10,795,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Equity Securities, FV-NI, Unrealized Gain (Loss)——————
Source

10-KT · 2023-05-01 · 0001437749-23-011946

2022-07-01 to 2022-09-30

————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2022Q3 2025Q3 2024Q3 2023Q3 2022Q2 2022Q1 2023Q1 2022FY 2025FY 2024FY 2023FY 2022
Cost of RevenueUSD————1,469,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

1,596,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

1,303,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

1,535,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

———6,179,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Operating Income (Loss)USD————-1,376,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

-1,635,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

-4,208,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

-2,274,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

-113,564,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-90,886,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-40,941,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

-7,391,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD————————-104,428,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-80,427,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-40,106,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Income Tax Expense (Benefit)USD————————-793,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-2,097,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-2,651,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

0
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Net Income (Loss) Attributable to ParentUSD—-18,177,000
Source

10-Q · 2025-11-10 · 0001193125-25-274328

2025-01-01 to 2025-03-31

-12,284,000
Source

10-Q · 2025-11-10 · 0001193125-25-274328

2024-01-01 to 2024-03-31

-371,000
Source

10-Q · 2024-11-12 · 0000950170-24-125399

2023-01-01 to 2023-03-31

-1,347,000
Source

10-Q · 2023-11-14 · 0001437749-23-032036

2022-01-01 to 2022-03-31

-1,604,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

-4,068,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

-2,243,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

-103,121,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-79,279,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-46,508,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

-7,272,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Earnings Per Share, BasicUSD per share————————-1.4
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-1.23
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-0.17
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

-0.05
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Earnings Per Share, DilutedUSD per share————————-1.4
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-1.23
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Total Revenue————————————
Weighted Average Number of Shares Outstanding, Basicshares————————73,813,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

64,425,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

267,643,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

141,987,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Weighted Average Number of Shares Outstanding, Dilutedshares————————73,813,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

64,425,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Additional Financial Items
Amortization of Intangible AssetsUSD————————7,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

7,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

7,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

41,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Current Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

0
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Depreciation, Depletion and Amortization, NonproductionUSD————————3,251,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

2,306,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Foreign Currency Transaction Gain (Loss), before TaxUSD————————-250,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

———
General and Administrative ExpenseUSD————1,581,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

1,618,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

3,114,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

1,840,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

30,233,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

26,613,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

21,064,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

6,621,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Goodwill, Impairment LossUSD————————0
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

24,062,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Gross ProfitUSD————1,441,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

1,220,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

414,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

1,029,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

——1,434,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

4,616,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-104,428,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-79,989,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Income (Loss) from Continuing Operations, Per Basic ShareUSD per share————————-1.41
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-1.22
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-0.14
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share————————-1.41
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-1.22
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

——
Income (Loss) from Equity Method InvestmentsUSD————————-2,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

-8,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

-17,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Interest ExpenseUSD——————————84,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

—
Investment Income, InterestUSD————29,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

31,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

140,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

31,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

8,114,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

10,515,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

934,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

119,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Marketing and Advertising ExpenseUSD———————————129,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Net Income (Loss) Available to Common Stockholders, BasicUSD————-1,347,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

-1,604,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

—-2,243,000
Source

10-Q · 2021-11-10 · 0001437749-21-026208

2021-07-01 to 2021-09-30

———-7,272,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Nonoperating Income (Expense)USD————29,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

31,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

140,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

31,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

9,136,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

10,459,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

835,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

119,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Operating ExpensesUSD————2,817,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

2,855,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

4,622,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

3,303,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

114,448,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

92,340,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

42,375,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

12,007,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Operating Lease, ExpenseUSD————78,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

79,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

79,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

78,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

100,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

800,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

97,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

312,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Preferred Stock Dividends, Income Statement ImpactUSD————0
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

0
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

—0
Source

10-Q · 2021-11-10 · 0001437749-21-026208

2021-07-01 to 2021-09-30

———0
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Research and Development ExpenseUSD————549,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

535,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

708,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

702,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

84,215,000
Source

10-K · 2026-03-16 · 0000728387-26-000004

2025-01-01 to 2025-12-31

41,638,000
Source

10-K/A · 2025-03-28 · 0000950170-25-046758

2024-01-01 to 2024-12-31

21,311,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

2,582,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Revenue from Contract with Customer, Including Assessed TaxUSD————2,910,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

2,816,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

1,717,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

2,564,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

——1,434,000
Source

10-K · 2024-03-28 · 0001437749-24-009696

2023-01-01 to 2023-12-31

10,795,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Selling and Marketing ExpenseUSD————687,000
Source

10-Q · 2022-05-13 · 0001437749-22-012202

2022-01-01 to 2022-03-31

702,000
Source

10-Q · 2022-02-09 · 0001437749-22-002803

2021-10-01 to 2021-12-31

800,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2022-07-01 to 2022-09-30

761,000
Source

10-Q · 2022-11-14 · 0001437749-22-027304

2021-07-01 to 2021-09-30

———2,804,000
Source

10-K · 2022-09-28 · 0001437749-22-023188

2021-07-01 to 2022-06-30

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

catx-ex99_1.htm · 8-K · 2026-11-09

Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2026 Results • Updated interim data from the Phase 1/2a bamzireotide navoxetan (VMT-α-NET) presentations continue to support an emerging therapeutic window and potential to achieve a best-in-class profile in NETs • Meaningful antitumor activity observed for lapemelanotide zapixetar (VMT01) monotherapy in metastatic melanoma to be evaluated with additional patients • PSV359 received Fast Track Designation from the FDA…

8-K · 2026-11-09 · 0001193125-26-453708

Read attachment ↗
catx-ex99_2.htm · 8-K · 2026-11-09

Next-Generation Radiopharmaceuticals Redefining Targeted Oncology Designed to be the Most Potent Payload in Targeted Oncology Three Independent Clinical-Stage Programs, Each Against a Distinct Target with Data in 2027 Deep Leadership Across Radiopharmaceutical and Drug Development The Perspective Story in Four Parts Radiopharmaceutical Therapy: A Category Still Early in Its Adoption Curve Targeted Delivery of Payloads is Transforming Oncology Therapy $45 Billion+ Addressable Market, Alre…

8-K · 2026-11-09 · 0001193125-26-453708

Read attachment ↗
catx-ex99_1.htm · 8-K · 2026-11-06

Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide Zapixetar (VMT01) Monotherapy Data from a Phase 1/2a Study in Heavily Pretreated Advanced Melanoma Patients at SITC 2026 • Meaningful antitumor activity observed at the 3.0 mCi monotherapy dose with 75% disease control rate and durable disease stabilization; one of two confirmed responders remains on study ~40 weeks after the first treatment • No dose-limiting toxicities, treatment-related serious adverse events, or discontinuat…

8-K · 2026-11-06 · 0001193125-26-451227

Read attachment ↗
catx-ex99_2.htm · 8-K · 2026-11-06

A Phase I/IIa Trial of [212Pb]VMT01 MC1R-targeted Alpha-Particle Mono- and Combination-Therapy with Nivolumab in Participants with Previously Treated Unresectable or Metastatic Melanoma M.S. Block1, Z.S. Morris2, J. Lutzky3, R.L. Wahl4, A.J. Olszanski5, Y. Menda6, S. Mehr7, L. Baratto8, S. Ayuk8, D. Pomponio8, S. Patel8, M. Puhlmann8, R.B. Patel9, and R. Arays10 1Mayo Clinic, Rochester, MN; 2University of Wisconsin, Madison, WI; 3University of Miami, Miami, FL; 4Washington University School of …

8-K · 2026-11-06 · 0001193125-26-451227

Read attachment ↗
catx-ex99_1.htm · 8-K · 2026-11-06

Perspective Therapeutics Presents Encouraging Incremental Data and Analyses from Phase 1/2a Trial of [212Pb]Bamzireotide Navoxetan (VMT-α-NET) in Advanced SSTR2 Expressing NETs • Additional analyses presented at NANETS 2026 Multidisciplinary NET Medical Symposium support prior findings of durable ongoing disease control and encouraging responses in all three cohorts across multiple patient populations • Preliminary evidence of more robust anti-tumor activity and durable responses in GEP-NET pa…

8-K · 2026-11-06 · 0001193125-26-450709

Read attachment ↗
catx-ex99_1.htm · 8-K · 2026-10-23

Perspective’s [212Pb]Bamzireotide Navoxetan (VMT-α-NET) Demonstrates Encouraging Safety, Durable Disease Control, and Robust Tumor Response Across Multiple Dose Cohorts in Phase 1/2a Trial in Advanced SSTR2-Expressing NETs • Results presented at ESMO show a promising therapeutic index for [212Pb]VMT-α-NET • Durable disease control in all three cohorts and 72% PFS at 18 months across all patients who received at least one treatment • Robust activity observed at three dose levels across patient…

8-K · 2026-10-23 · 0001193125-26-429770

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.